Swallowable robot-camera could spot stomach cancer early

NCT ID NCT07323186

Not yet recruiting Diagnosis Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, less invasive way to screen for stomach cancer using a magnetic-guided video capsule that patients swallow. The capsule is steered by a robot and uses AI to check the stomach for suspicious spots. Researchers will compare its accuracy to standard endoscopy in 100 adults aged 50-74 who are already having a colonoscopy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Magnetically controlled video capsule endoscopy (MC-VCE) device
What this could lead to: If successful, this could offer a less invasive, more accessible screening method for early stomach cancer, potentially improving survival rates.
What could go wrong: This is an early-stage study with only 100 participants, and the capsule may miss lesions that standard endoscopy finds. It is not yet proven for widespread screening.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIAGNOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIAGNOSIS ENDOSCOPY OF STOMACH (PROCEDURE) STOMACH CANCER

Contacts and locations

Locations

Nantes University Hospital

Nantes, 44000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.